- Home
- PHAT vs MVIS Comparison
PHAT vs MVIS Comparison
Compare PHAT & MVIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- MVIS
- Stock Information
- Founded
- PHAT 2018
- MVIS 1993
- Country
- PHAT United States
- MVIS United States
- Employees
- PHAT N/A
- MVIS N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- MVIS Industrial Machinery/Components
- Sector
- PHAT Health Care
- MVIS Technology
- Exchange
- PHAT Nasdaq
- MVIS Nasdaq
- Market Cap
- PHAT 289.0M
- MVIS 287.6M
- IPO Year
- PHAT 2019
- MVIS 1996
- Fundamental
- Price
- PHAT $4.25
- MVIS $1.10
- Analyst Decision
- PHAT Strong Buy
- MVIS Buy
- Analyst Count
- PHAT 4
- MVIS 4
- Target Price
- PHAT $16.25
- MVIS $2.50
- AVG Volume (30 Days)
- PHAT 2.2M
- MVIS 4.8M
- Earning Date
- PHAT 05-01-2025
- MVIS 05-12-2025
- Dividend Yield
- PHAT N/A
- MVIS N/A
- EPS Growth
- PHAT N/A
- MVIS N/A
- EPS
- PHAT N/A
- MVIS N/A
- Revenue
- PHAT $81,859,000.00
- MVIS $4,329,000.00
- Revenue This Year
- PHAT $195.45
- MVIS $481.03
- Revenue Next Year
- PHAT $106.76
- MVIS $95.03
- P/E Ratio
- PHAT N/A
- MVIS N/A
- Revenue Growth
- PHAT 3055.70
- MVIS N/A
- 52 Week Low
- PHAT $2.21
- MVIS $0.80
- 52 Week High
- PHAT $19.71
- MVIS $1.95
- Technical
- Relative Strength Index (RSI)
- PHAT 54.83
- MVIS 46.45
- Support Level
- PHAT $3.92
- MVIS $1.04
- Resistance Level
- PHAT $4.35
- MVIS $1.38
- Average True Range (ATR)
- PHAT 0.40
- MVIS 0.10
- MACD
- PHAT 0.13
- MVIS 0.01
- Stochastic Oscillator
- PHAT 85.63
- MVIS 26.32
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About MVIS MicroVision Inc.
Microvision Inc is engaged in developing a lidar sensor to be used in automotive safety and autonomous driving applications. Its lidar sensor uses laser beam scanning (LBS) technology, which is based on systems that include micro-electrical mechanical systems (MEMS), laser diodes, opto-mechanics, electronics, algorithms, and software. The company has also developed solutions for Augmented Reality, Interactive Displays, and Consumer Lidars.